Status:
TERMINATED
Apraxia in Parkinson's Disease Patients With Deep Brain Stimulation
Lead Sponsor:
University of Florida
Conditions:
Deep Brain Stimulation
Parkinson Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Deep brain stimulation (DBS) of the subthalamic nucleus or globus pallidus internus can improve motor symptoms Parkinson's disease (PD). However, it is not known whether DBS can help reduce the signs ...
Detailed Description
This will be a pilot study designed to assess the safety and feasibility of an apraxia testing protocol in chronically implanted PD DBS patients. We hypothesize that apraxia testing in the DBS ON and ...
Eligibility Criteria
Inclusion
- Patients with PD as defined by the UK Brain Bank Criteria
- Male or female, ages 18 to 80 years old
- Chronically implanted DBS of either the STN or GPi for a minimum of 6 months
Exclusion
- Other neurological diagnoses (e.g. Alzheimer's disease, atypical parkinsonism, stroke)
- History of previous neurosurgical intervention that was not DBS
- Patients with DBS of targets other than the STN or GPi, or leads in both targets
- Patients in whom there is poor manual dexterity for a reason other than PD (e.g. orthopedic injury, amputation)
- Patients with a diagnosis of PD dementia
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 28 2024
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04725773
Start Date
June 1 2021
End Date
January 28 2024
Last Update
July 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UF Health at the University of Florida
Gainesville, Florida, United States, 32608